Abstract S1-05: A randomized, double-blinded, placebo-controlled clinical trial of extended adjuvant endocrine therapy (tx) with letrozole (L) in postmenopausal women with hormone-receptor (+) breast cancer (BC) who have completed previous adjuvant tx with an aromatase inhibitor (AI): Results from NRG Oncology/NSABP B-42-Reference-Cited by-同舟云学术

Abstract S1-05: A randomized, double-blinded, placebo-controlled clinical trial of extended adjuvant endocrine therapy (tx) with letrozole (L) in postmenopausal women with hormone-receptor (+) breast cancer (BC) who have completed previous adjuvant tx with an aromatase inhibitor (AI): Results from NRG Oncology/NSABP B-42

Published:2017-02-14 Issue: Volume: Page:
ISSN:
Container-title:General Session Abstracts
language:
Short-container-title:

Author:

Mamounas EP,Bandos H,Lembersky BC,Geyer CE,Fehrenbacher L,Graham ML,Chia SL,Brufsky AM,Hennessy BT,Soori GS,Dakil SR,Seay TE,Wade JL,McCarron EC,Paik S,Swain SM,Wickerham DL,Wolmark N

Publisher

American Association for Cancer Research

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Atezolizumab Monotherapy or Combined Therapy with Chemotherapy in Patients with Metastatic Triple-negative Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials;Current Pharmaceutical Design;2023-09

2. Extended adjuvant endocrine therapy for women with hormone receptor-positive early breast cancer: A meta-analysis with trial sequential analysis of randomized controlled trials;Frontiers in Oncology;2022-10-27

3. Extended endocrine therapy in breast cancer: A basket of length-constraint feature selection metaheuristics to balance Type I against Type II errors;Journal of Biomedical Informatics;2022-07

4. Mexican consensus on breast cancer diagnosis and treatment;Gaceta Mexicana de Oncolog�a;2021-11-24

5. Super Magnetic Niosomal Nanocarrier as a New Approach for Treatment of Breast Cancer: A Case Study on SK-BR-3 and MDA-MB-231 Cell Lines;International Journal of Molecular Sciences;2021-07-26